Zachary T. Bloomgarden, MD, Editor of the Journal of Diabetes and a Clinical Professor at the Mount Sinai School of Medicine, provides a critical analysis of the recent FDA decision of keeping Avandia on the market.
Disclosures:Speaker’s Bureau: Merck, NovoNordisk, GSKAdvisory Panel: Merck, BMS,...